Dyne Therapeutics, Inc.
Price Action
Technical Summary
EMERGING TRENDDyne Therapeutics, Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is moderate (RS Rating: 66), indicating performance broadly in line with the market. Earnings growth of 14% provides fundamental context to the price action. Investors should exercise caution due to high volatility (86% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $18.79 | +0.27% | ABOVE |
| 50 SMA | $18.02 | +4.55% | ABOVE |
| 100 SMA | $17.95 | +4.99% | ABOVE |
| 150 SMA | $18.21 | +3.46% | ABOVE |
| 200 SMA | $16.69 | +12.88% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is DYN in an uptrend right now?
DYN has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is DYN overbought or oversold?
DYN's RSI (14) is 43. The stock is in neutral territory, neither overbought nor oversold.
Is DYN outperforming the market?
DYN has a Relative Strength (RS) Rating of 66 out of 99. DYN is performing about average compared to the market.
Where is DYN in its 52-week range?
DYN is trading at $18.84, which is 75% of its 52-week high ($25.00) and 64% above its 52-week low ($8.06).
How volatile is DYN?
DYN has a Beta of 2.34 and 52-week volatility of 86%. It's more volatile than the S&P 500 - expect bigger swings.